<DOC>
	<DOCNO>NCT00985504</DOCNO>
	<brief_summary>The purpose study provide comparison apathy , depression , functional outcome associate switch duloxetine escitalopram patient previously respond treatment selective serotonin reuptake inhibitor ( SSRI ) major depressive disorder residual apathy absence depress mood .</brief_summary>
	<brief_title>A Study Patients With Major Depressive Disorder Residual Apathy</brief_title>
	<detailed_description>Apathy report 30 % patient major depressive disorder ( MDD ) hypothesize treatment emergent adverse effect associate selective serotonin reuptake inhibitor medication . While currently consistent method treat apathy among psychiatrist , propose switch MDD patient antidepressant medication contain serotonin norepinephrine , duloxetine , may reduce incidence severity apathy patient .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Have receive treatment SSRI ( escitalopram , sertraline , paroxetine , citalopram ) major depressive disorder Females childbearing potential test negative pregnancy time enrollment base urine pregnancy test agree use reliable method birth control Apathy Evaluation Scale Clinician Rated Version ( AESC ) total score &gt; 30 screen randomization . MontgomeryAsberg Depression Rating Scale ( MADRS ) total score â‰¤15 Item 1 ( apparent sadness ) score &lt; 2 screen randomization . Have level understanding sufficient provide inform consent communicate investigator , study coordinator , site personnel . Are currently enrol , discontinue within last 30 day , clinical trial involve offlabel use investigational drug device Have previously complete withdrawn study study investigate duloxetine . Have previous lack response adequate trial duloxetine within past 12 month escitalopram time . Diagnostic Statistical Manual Mental Disorders , 4th Edition ( DSMIV ) , diagnosis mania , bipolar disorder , treatment resistant depression psychosis ; current suicide risk Diagnostic Statistical Manual Mental Disorders , Fourth Edition , Text Revision ( DSMIVTR ) , substance abuse dependence within 6 month Presence Axis II disorder Monoamine oxidase inhibitor ( MAOI ) treatment within 14 day prior randomization potential need use MAOI study Positive urine drug screen substance abuse exclude medication . Are pregnant breastfeeding . Serious medical illness , require hospitalization study Have uncontrolled narrowangle glaucoma . Have acute liver injury severe cirrhosis Abnormal thyroid stimulate hormone ( TSH ) concentration Amphetamines , dopaminergic medication modafinil within 14 day prior randomization potential need use medication study within 14 day discontinuation study drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Apathy</keyword>
	<keyword>Duloxetine Hydrochloride</keyword>
	<keyword>SSRI</keyword>
	<keyword>Escitalopram</keyword>
</DOC>